You are using an older browser version. Please use a supported version for the best MSN experience.

Gilead Study Suggests Remdesivir Reduces Mortality Rate in COVID Patients

Gilead found that patients treated with remdesivir showed a 62% reduction in mortality rates.
image beaconimage beaconimage beacon